A CNRS research fellow since 2002, I carried out my work on the Jussieu campus and then at the Institut Pasteur de Paris between 2013 and 2024 before joining the Centre de Biologie Intégrative (CBI) in September 2024.
Between 2013 and 2017, I helped demonstrate the role of the RNF213 gene in resistance to Rift Valley Fever (RVF) in mice. From 2017 to 2024, I participated in the characterization of the first enhancer regulating SRY gene expression to be identified in mammals, and proposed that this regulatory element has existed since the origin of this group. This work led to the identification of a new cause of Sexual Determination Defect (SDD) in humans.
My current research focuses on the impact of metabolic alterations, particularly in the folate pathway, on brain development in humans and mice. To this end, I am interested in the evolution of the gene encoding DiHydroFolate Reductase (DHFR) in mammals, and how its translation is regulated by its own protein. This approach has led me to explore how certain isoforms of DHFR might contribute to controlling its protein level in humans.